Harris Teeter expands GLP-1 access
Regional grocer integrates medications, dietitians and affordability tools to support weight management.
Regional grocer integrates medications, dietitians and affordability tools to support weight management.
Medicare pricing reforms weigh on pharmacy sales while core retail performance remains stable.
Eligible self-pay patients can access the oral diabetes treatment for as low as $149 per month.
"PCMA strongly supports real-time benefit tools, which not only provide visibility for patients but ensure providers consider the cost associated with therapeutically-equivalent medications."
As consumers increasingly prioritize preventive health, demand is rising for supplements supporting cognitive, joint, and immune health, reinforcing pharmacy’s expanding role.
Weight-loss drugs drive historic growth in 2025.
This recognition follows a defining period of momentum for Sprout and its flagship treatment, Addyi.
Pharmacy delivery scale and integrated GLP-1 care emerge as key healthcare growth drivers in Amazon’s first quarter.
Food Allergy Fund Debuts Caregiver resource with Dr. Becky Kennedy, alongside breakthroughs in food allergy detection and treatment.
The collaboration integrates AssureCare’s Akumen analytics platform with Pillr Health’s Pharmacy Accelerator solution, creating a more data-driven framework for health systems to build and optimize in-house specialty pharmacy programs.
Dr. Reddy’s becomes the first company to receive marketing authorization for generic Semaglutide Injection in Canada.
Customers can pick up eligible prescriptions curbside through DriveUp & Go; new pharmacy customers may be eligible for grocery savings.
Teams such as the Yankees, Red Sox, Cardinals, Giants, Padres, and Angels are joining Merck to help educate fans about high bad cholesterol and how it may increase the risk of heart attack or stroke
Camber Pharmaceuticals aims to expand in the U.S. generics market. President Kon Ostaficiuk highlights a strategy focused on scale, speed, and competitiveness.
Combined Business leverages complementary portfolios and global scale for sustained long‑term value creation.
Expands options for cash-paying patients to access the nation’s No. 1 prescribed oral blood thinner